TABLE 3.
Cumulative life-years gained for 2015–2030 with each policy option1
| Price decreased by 10% | Price decreased by 30% | MMC decaying impact | |
| CAD | 1,363,900 (1,301,000, 1,424,600) | 4,044,500 (3,869,400, 4,197,000) | 152,800 (143,900, 161,500) |
| Men | 823,200 (776,000, 871,200) | 2,440,900 (2,297,100, 2,571,200) | 97,200 (89,600, 104,400) |
| Women | 540,700 (507,500, 579,300) | 1,603,600 (1,504,500, 1,699,600) | 55,600 (50,800, 60,500) |
| Stroke | 1,099,500 (1,038,000, 1,160,800) | 3,214,500 (3,026,500, 3,377,100) | 127,300 (118,700, 135,400) |
| Men | 484,000 (438,200, 538,400) | 1,414,700 (1,285,900, 1,559,100) | 60,400 (54,400, 66,100) |
| Women | 615,600 (573,900, 653,700) | 1,799,900 (1,677,000, 1,918,600) | 66,900 (61,200, 72,600) |
| CVD | 2,463,400 (2,371,600, 2,551,100) | 7,259,000 (7,000,600, 7,471,500) | 280,100 (266,900, 291,100) |
| Men | 1,307,200 (1,240,300, 1,378,600) | 3,855,500 (3,652,600, 4,045,100) | 157,600 (147,900, 166,700) |
| Women | 1,156,300 (1,100,200, 1,208,800) | 3,403,400 (3,241,900, 3,554,900) | 122,500 (114,600, 130,100) |
1
Values are numbers (95% CIs). Numbers of life-years gained are cumulative from 2015 to 2030. MMC “decaying impact” models refer to a 1-y MMC. Data are stratified by CVD subtype and sex. Results are rounded to the nearest 100. CAD, coronary artery disease; CVD, cardiovascular disease; MMC, mass media campaign.